Figure 3.
Survival analysis of in-house pancreatic cancer cases stratified by the LOXL2 expression level based on combined staining range and staining concentration grades (more than 4 was regarded as high expression). (A) Kaplan-Meier Analysis for Disease-free survival (DFS). (B) Kaplan-Meier Analysis for overall survival (OS). Both DFS and OS of cases with high LOXL2 expression were significantly worse than the cases with low LOXL2 according to the log-rank test.